The Board granted an effective date of November 22, 2021, for the grant of service connection for chronic myeloid leukemia (CML) and a 100 percent evaluation for CML for the period prior to March 1, 2025.
The deciding factor: The Veteran's claim was continuously pursued since November 22, 2021, and the evidence supports that his condition required continuous myelosuppressive therapy treatment.
- Claimed conditions
- chronic myeloid leukemia (CML)
- How they argued it
- Reopened with new and material evidence
- Exposure basis
- None
- Rating assigned
- 100%
- Decision date
- April 4, 2025
- Citation
- A25031390
What this means for you
A grant means the Board agreed the veteran was entitled to the benefit. Decisions like this show the kind of evidence and arguments that tend to succeed for claims like it.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Denied
The Board denied service connection for chronic myeloid leukemia as the evidence of record does not support a finding that it is etiologically related to the Veteran's military service.
- Granted
The Board granted service connection for chronic myeloid leukemia based on the Veteran's exposure to toxic burn pits during his service in Afghanistan.
- Granted
The Board granted service connection for chronic myeloid leukemia, finding that the evidence is at least evenly balanced as to whether it is causally related to the Veteran's active-duty service.
- Granted
The Board granted service connection for chronic myeloid leukemia, finding that the Veteran's condition is causally or etiologically related to in-service exposure to toxic substances from burn pits.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.